We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PI:NASDAQImpinj, Inc. Analysis

Data as of 2026-04-24 - not real-time

$123.91

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Impinj (PI) trades at $123.9, well above its 20‑day (≈$108) and 50‑day (≈$108) simple moving averages but still below the 200‑day average (≈$154), indicating a short‑term bullish bias within a longer‑term bearish framework. The RSI of 68 signals near‑overbought conditions, while a bullish MACD histogram (+$2.65) suggests upward momentum may persist in the near term. Volume is accelerating, and the price is flirting with the identified resistance around $126.5, making a breakout possible but also raising the risk of a pullback to the support near $95. Fundamentals remain weak – operating margins are negative, ROE is below zero, and the DCF fair value (~$14) is dramatically lower than the market price, flagging a substantial valuation gap. Nonetheless, forward EPS forecasts turn positive (~$3.12) and analysts maintain a “buy” consensus with a median target near $172, implying an upside of roughly 30% if the turnaround materializes. The market sentiment is extremely bullish (Fear‑Greed Index 88), but the stock’s high beta (≈2.0) and 30‑day volatility (≈42%) underscore considerable risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price approaching resistance with high RSI
  • Bearish long‑term trend despite bullish MACD
  • Elevated volatility and beta increasing downside risk

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward EPS turning positive and analyst buy consensus
  • Increasing volume supporting momentum
  • Potential upside of ~30% relative to current price

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Fundamental gaps: negative margins and low DCF valuation
  • Industry tailwinds in RFID and IoT applications
  • High beta and volatility may dampen long‑term returns

Key Metrics & Analysis

Financial Health

Revenue Growth1.40%
Profit Margin-3.00%
P/E Ratio39.8
ROE-6.04%
ROA-0.09%
Debt/Equity145.39
P/B Ratio17.9
Op. Cash Flow$58.7M
Free Cash Flow$38.8M
Industry P/E38.1

Technical Analysis

TrendBearish
RSI68.4
Support$94.89
Resistance$126.50
MA 20$107.81
MA 50$108.44
MA 200$153.88
MACDBullish
VolumeIncreasing
Fear & Greed Index88.02

Valuation

Fair Value$14.06
Target Price$163.88
Upside/Downside32.25%
GradeOvervalued
TypeBlend

Risk Assessment

Beta2.05
Volatility42.20%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.